BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3953203)

  • 1. Prognostic value of nuclear DNA content in follicular thyroid tumours.
    Bäckdahl M; Auer G; Forsslund G; Granberg PO; Hamberger B; Lundell G; Löwhagen T; Zetterberg A
    Acta Chir Scand; 1986 Jan; 152():1-7. PubMed ID: 3953203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear DNA content and prognosis in Hürthle cell tumours of the thyroid gland.
    Wallin G; Bäckdahl M; Lundell G; Auer G; Löwhagen T
    Acta Chir Scand; 1988 Sep; 154(9):501-4. PubMed ID: 3201861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical meaning of DNA content in the long term behaviour of follicular thyroid tumours: a 12-year follow up.
    Lukács GL; Balázs G; Zs-Nagy I; Mikó T
    Eur J Surg; 1994 Aug; 160(8):417-23. PubMed ID: 7811827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nuclear DNA content of thyroid adenocarcinoma].
    Yoshida A
    Nihon Geka Gakkai Zasshi; 1984 Oct; 85(10):1261-73. PubMed ID: 6503946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear DNA measurements in follicular thyroid adenomas.
    Bäckdahl M; Wallin G; Askensten U; Auer G; Grimelius L; Löwhagen T
    Eur J Surg Oncol; 1989 Apr; 15(2):125-9. PubMed ID: 2703057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of cellular DNA content in thyroid tumors by the flow cytometer].
    Motomura Y
    Nihon Geka Gakkai Zasshi; 1988 Jul; 89(7):1066-74. PubMed ID: 3221827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA cytophotometry of oxyphilic thyroid tumors].
    Pilch H; Back W; Winter J
    Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis between follicular adenoma and follicular carcinoma of the thyroid by nuclear DNA determination.
    Sprenger E; Löwhagen T; Vogt-Schaden M
    Acta Cytol; 1977; 21(4):528-30. PubMed ID: 269603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of nuclear DNA content in primary and metastatic papillary thyroid carcinoma.
    Bäckdahl M; Cohn K; Auer G; Forsslund G; Granberg PO; Lundell G; Löwhagen T; Willems JS; Zetterberg A
    Cancer Res; 1985 Jun; 45(6):2890-4. PubMed ID: 3986815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study.
    Wallin G; Bäckdahl M; Tallroth-Ekman E; Lundell G; Auer G; Löwhagen T
    Eur J Surg Oncol; 1989 Feb; 15(1):43-8. PubMed ID: 2465188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of DNA content in carcinoma of the rectum and rectosigmoid.
    Enblad P; Glimelius B; Bengtsson A; Pontén J; Påhlman L
    Acta Chir Scand; 1987; 153(7-8):453-8. PubMed ID: 3673455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nuclear DNA pattern of thyroid tumor].
    Tanaka H
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1239-46. PubMed ID: 1403317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
    Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
    Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic significance of nuclear DNA content in highly malignant thyroid tumors].
    Lukács G; Balázs G; Zs-Nagy I; Juhász F
    Wien Klin Wochenschr; 1990 Apr; 102(9):253-6. PubMed ID: 2375112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of blood vessel invasion by cells of thyroid follicular carcinoma using image processing combined with immunohistochemistry].
    Zhu QY
    Zhonghua Yi Xue Za Zhi; 1989 Oct; 69(10):573-5, 40. PubMed ID: 2620265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image cytometric DNA analysis of adrenocortical neoplasms as a prognostic parameter: a clinico-pathologic study of 13 patients.
    Lü X; Stallmach T; Gebbers JO
    Anal Cell Pathol; 1996 Oct; 12(1):1-11. PubMed ID: 8933905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the nucleolar organizer regions (NORs) in the thyroid follicular tumours. Comparison of the cytological and histopathological examinations.
    Musiatowicz B; Dziecioł J; Augustynowicz A; Miller-Famulska D; Sulik M; Famulski W; Chabowski A; Jabłońska E; Andrzejewicz A; Mielech W; Guzińska-Ostymowicz K
    Rocz Akad Med Bialymst; 1998; 43():186-93. PubMed ID: 9972054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.